Tumor‐vascular interactions and tumor dormancy
Open Access
- 1 July 2008
- Vol. 116 (7-8) , 569-585
- https://doi.org/10.1111/j.1600-0463.2008.01213.x
Abstract
Tumor progression is dependent on a number of sequential steps, including initial tumor‐vascular interactions and recruitment of blood vessels (i.e., the angiogenic switch), as well as tumor cells interacting with the surrounding microenvironment and its different components. Failure of a microscopic tumor to complete one or more of these early stages may lead to delayed clinical manifestation of the cancer and a state of stable non‐progressing disease (i.e., tumor dormancy). In this review, some of the clinical and experimental evidence is summarized, suggesting that microscopic human cancers, either primary, recurrent or metastatic, can remain in an asymptomatic, non‐detectable, and occult state for a long period of time. We also review current experimental human tumor dormancy models which closely recapitulate clinically observed delay in tumor progress.Keywords
This publication has 97 references indexed in Scilit:
- Models, mechanisms and clinical evidence for cancer dormancyNature Reviews Cancer, 2007
- A Model of Human Tumor Dormancy: An Angiogenic Switch From the Nonangiogenic PhenotypeJNCI Journal of the National Cancer Institute, 2006
- RETRACTED: Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesisCancer Cell, 2003
- Clinical translation of angiogenesis inhibitorsNature Reviews Cancer, 2002
- The Hallmarks of CancerCell, 2000
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Induction of angiogenesis during the transition from hyperplasia to neoplasiaNature, 1989
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971